Can propranolol cause hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Propranolol Cause Hair Loss?

Yes, propranolol can cause hair loss, though it is an uncommon side effect that typically presents as reversible telogen effluvium. The FDA drug label lists alopecia as a documented adverse reaction 1, and this is supported by case reports and pharmacovigilance data.

Evidence from FDA Drug Label

The official FDA labeling for propranolol explicitly lists alopecia among its adverse reactions under "Skin and mucous membranes" 1. This represents the highest quality evidence available, as drug labels reflect post-marketing surveillance and clinical trial data.

Clinical Characteristics

When propranolol-induced hair loss occurs, it characteristically manifests as:

  • Telogen effluvium pattern: Documented in case reports showing this specific type of hair loss on scalp biopsy 2, 3
  • Diffuse, non-scarring alopecia: Rather than patchy or localized loss 4
  • Reversible: Hair regrowth typically occurs after discontinuation or dose reduction 5, 4

Incidence and Context

The actual incidence appears to be low. Among beta-blockers as a class, hair loss is reported but uncommon 6. A comprehensive review of psychopharmacology noted that while many cardiovascular medications can cause alopecia, it occurs in only a small percentage of patients 4. More recent pharmacovigilance analysis of the FDA's adverse events database did not list beta-blockers among the most frequently reported drug classes for alopecia 7.

Clinical Management Algorithm

If a patient on propranolol develops diffuse hair loss:

  1. Rule out other causes first: Thyroid dysfunction (which propranolol can mask), nutritional deficiencies, other medications, stress, or underlying medical conditions
  2. Assess temporal relationship: Hair loss typically begins 2-4 months after starting the medication (reflecting the telogen effluvium timeline)
  3. Consider dose-response: Some drug-induced alopecias are dose-dependent
  4. Evaluate cardiovascular indication: Determine if propranolol is essential or if alternative therapy is feasible
  5. If propranolol is necessary: Continue therapy with patient reassurance about reversibility
  6. If alternative possible: Switch to a different antihypertensive or beta-blocker with potentially lower risk, or reduce dose

Important Caveats

  • Do not confuse with topical propranolol: Interestingly, topical propranolol is being investigated as a treatment for stress-induced hair loss by blocking sympathetic nerve effects 8, which is mechanistically distinct from systemic drug-induced telogen effluvium
  • Documentation matters: Because hair loss has multiple causes, establishing causality requires temporal correlation and ideally improvement after drug discontinuation 4
  • Patient compliance: Awareness of this potential side effect is important, as unreported alopecia may contribute to medication non-adherence 5

The bottom line: While propranolol can cause hair loss, it is uncommon, reversible, and should not automatically warrant discontinuation unless the cosmetic concern outweighs the cardiovascular benefit or alternative therapy is equally effective.

References

Research

Propranolol and alopecia.

Cutis, 1979

Research

Metoprolol and alopecia.

Cutis, 1981

Research

Hair loss in psychopharmacology.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2000

Research

[Drug induced alopecia].

Nederlands tijdschrift voor geneeskunde, 1999

Research

A single-center clinical trial evaluating topical propranolol for preventing stress-induced hair loss.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.